Sign Out
It is a general principle of pharmacotherapy that during pregnancy and the lactation period medicinal products should only be used after careful consideration of the risks and benefits.
Pregnant women and those who are breast-feeding should therefore only undergo treatment with thioctic acid if the doctor determines that this is strictly indicated, even though reproduction toxicological studies have not shown any indications that fertility or early embryo development are affected and the medicinal product has not been found to have any embryotoxic properties.
It is not known whether thioctic acid passes into the mother's milk.
Continue with Google